{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:17:32Z","timestamp":1793128652292,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ejpn.2022.03.005","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T20:42:59Z","timestamp":1649104979000},"page":"62-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["The Unified Batten Disease Rating Scale (UBDRS): Validation and reliability in an independent CLN3 disease sample"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7451-3616","authenticated-orcid":false,"given":"Eva","family":"Wibbeler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1870-1142","authenticated-orcid":false,"given":"Miriam","family":"Nickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3716-1575","authenticated-orcid":false,"given":"Christoph","family":"Schwering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Mink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2022.03.005_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1212\/WNL.0b013e31825f0547","article-title":"New nomenclature and classification scheme for the neuronal ceroidlipofuscinoses","volume":"79","author":"Williams","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2022.03.005_bib2","series-title":"The Neuronal Ceroid Lipofuscinoses (Batten Disease)","first-page":"24","author":"Mole","year":"2011"},{"key":"10.1016\/j.ejpn.2022.03.005_bib3","first-page":"73","article-title":"Juvenile neuronal ceroid lipofuscinosis (Batten disease): current insights","volume":"6","author":"Ostergaard","year":"2016","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"10.1016\/j.ejpn.2022.03.005_bib4","first-page":"1801","article-title":"NCL diseases- clinical perspectives","volume":"1832","author":"Schulz","year":"2013","journal-title":"Biochem. Biophys Acta."},{"key":"10.1016\/j.ejpn.2022.03.005_bib5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jnr.20367","article-title":"CLN3, the protein associated with batten disease: structure, function and localization","volume":"79","author":"Phillips","year":"2015","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.ejpn.2022.03.005_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/humu.21624","article-title":"Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses","volume":"33","author":"Kousi","year":"2012","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.ejpn.2022.03.005_bib7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1212\/01.wnl.0000169019.41332.8a","article-title":"A\u00a0clinical rating scale for Batten disease","volume":"65","author":"Marshall","year":"2005","journal-title":"Neurology"},{"issue":"20","key":"10.1016\/j.ejpn.2022.03.005_bib8","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1212\/WNL.0b013e318237f649","article-title":"Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease)","volume":"77","author":"Kwon","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ejpn.2022.03.005_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cct.2013.04.004","article-title":"Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates","volume":"35","author":"de Blieck","year":"2013","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.ejpn.2022.03.005_bib10","unstructured":"Gene Therapy for Children with CLN3 Batten Disease. 2018, December 10. Retrieved from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03770572."},{"key":"10.1016\/j.ejpn.2022.03.005_bib11","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1212\/WNL.0b013e31821435bd","article-title":"Cardiac involvement in juvenile neuronal ceroid lipofuscinosis (Batten disease)","volume":"76","author":"Ostergaard","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2022.03.005_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.autneu.2018.07.003","article-title":"Paroxysmal sympathetic hyperactivity in Juvenile neuronal ceroid lipofuscinosis (Batten disease)","volume":"214","author":"Ostergaard","year":"2018","journal-title":"Auton. Neurosci."},{"issue":"9","key":"10.1016\/j.ejpn.2022.03.005_bib13","doi-asserted-by":"crossref","first-page":"165643","DOI":"10.1016\/j.bbadis.2019.165643","article-title":"Cardiac pathology in neuronal ceroid lipofuscinoses (NCL): more than a mere co-morbidity","volume":"1866","author":"Rietdorf","year":"2020","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"23","key":"10.1016\/j.ejpn.2022.03.005_bib14","doi-asserted-by":"crossref","first-page":"e2436","DOI":"10.1212\/WNL.0000000000009454","article-title":"The CLN3 Disease Staging System: a new tool for clinical research in Batten disease","volume":"94","author":"Masten","year":"2020","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.ejpn.2022.03.005_bib15","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1080\/13543784.2020.1837110","article-title":"Batten disease: an expert update on agents in preclinical and clinical trials","author":"Masten","year":"2020","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"11\u201312","key":"10.1016\/j.ejpn.2022.03.005_bib16","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2119\/molmed.2010.00241","article-title":"Analysis of potential biomarkers and modifier genes affecting the clinical course of CLN3 disease","volume":"17","author":"Lebrun","year":"2011","journal-title":"Mol. Med."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109037982200040X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109037982200040X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:39:38Z","timestamp":1761071978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109037982200040X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":16,"alternative-id":["S109037982200040X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2022.03.005","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Unified Batten Disease Rating Scale (UBDRS): Validation and reliability in an independent CLN3 disease sample","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2022.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.","name":"copyright","label":"Copyright"}]}}